A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma

A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating and painful cancers. It is often highly resistant to therapy owing to inherent chemoresistance and the desmoplastic response that creates a barrier of fibrous tissue preventing transport of chemotherapeutics into the tumor. The g...

Full description

Bibliographic Details
Main Authors: Ligorio, Matteo (Author), Ting, David T. (Author), Xega, Kristina (Author), Tzafriri, Abraham R. (Author), Bersani, Francesca (Author), Aceto, Nicola (Author), Thapar, Vishal (Author), Fuchs, Bryan C. (Author), Deshpande, Vikram (Author), Baker, Aaron B. (Author), Ferrone, Cristina R. (Author), Haber, Daniel A. (Author), Clark, Jeffrey W. (Author), Edelman, Elazer R. (Author), Indolfi, Laura (Contributor), Langer, Robert S (Contributor)
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Elsevier, 2018-07-24T15:23:18Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items